Amedeo Smart

Free Medical Literature Service


 

Amedeo

Alzheimer's Disease

  Free Subscription

02.08.2021

1 Acta Neuropathol
5 Alzheimers Dement
1 Am J Geriatr Psychiatry
2 Ann Neurol
1 Brain
1 Dement Geriatr Cogn Disord
2 J Alzheimers Dis
2 J Biol Chem
2 Lancet Neurol
2 N Engl J Med
1 Nat Rev Neurol
1 Neurobiol Aging
1 Proc Natl Acad Sci U S A



    Acta Neuropathol

  1. CHEN CD, Joseph-Mathurin N, Sinha N, Zhou A, et al
    Comparing amyloid-beta plaque burden with antemortem PiB PET in autosomal dominant and late-onset Alzheimer disease.
    Acta Neuropathol. 2021 Jul 28. pii: 10.1007/s00401-021-02342.
    >> Share


    Alzheimers Dement

  2. BOADA M, Rodrigo A, Jessen F, Wimblad B, et al
    Complementary pre-screening strategies to uncover hidden prodromal and mild Alzheimer's disease: Results from the MOPEAD project.
    Alzheimers Dement. 2021 Jul 26. doi: 10.1002/alz.12441.
    >> Share

  3. GARNIER-CRUSSARD A, Bougacha S, Wirth M, Dautricourt S, et al
    White matter hyperintensity topography in Alzheimer's disease and links to cognition.
    Alzheimers Dement. 2021 Jul 28. doi: 10.1002/alz.12410.
    >> Share

  4. VAN HARTEN AC, Wiste HJ, Weigand SD, Mielke MM, et al
    Detection of Alzheimer's disease amyloid beta 1-42, p-tau, and t-tau assays.
    Alzheimers Dement. 2021 Jul 26. doi: 10.1002/alz.12406.
    >> Share

  5. KULMINSKI AM, Philipp I, Loika Y, He L, et al
    Protective association of the epsilon2/epsilon3 heterozygote with Alzheimer's disease is strengthened by TOMM40-APOE variants in men.
    Alzheimers Dement. 2021 Jul 26. doi: 10.1002/alz.12413.
    >> Share

  6. HOSCHEIDT S, Sanderlin AH, Baker LD, Jung Y, et al
    Mediterranean and Western diet effects on Alzheimer's disease biomarkers, cerebral perfusion, and cognition in mid-life: A randomized trial.
    Alzheimers Dement. 2021 Jul 26. doi: 10.1002/alz.12421.
    >> Share


    Am J Geriatr Psychiatry

  7. MORTBY ME, Adler L, Aguera-Ortiz L, Bateman DR, et al
    Apathy as a Treatment Target in Alzheimer's Disease: Implications for Clinical Trials.
    Am J Geriatr Psychiatry. 2021 Jul 1. pii: S1064-7481(21)00380.
    >> Share


    Ann Neurol

  8. TAN EK
    Genetic studies of Parkinson's & Alzheimer's disease in Latinos/Hispanics: New Insights & Challenges.
    Ann Neurol. 2021 Jul 26. doi: 10.1002/ana.26179.
    >> Share

  9. MONTAL V, Barroeta I, Bejanin A, Pegueroles J, et al
    Metabolite signature of Alzheimer's disease in adults with Down syndrome.
    Ann Neurol. 2021 Jul 26. doi: 10.1002/ana.26178.
    >> Share


    Brain

  10. PAUMIER A, Boisseau S, Jacquier-Sarlin M, Pernet-Gallay K, et al
    Astrocyte-neuron interplay is critical for Alzheimer's disease pathogenesis and is rescued by TRPA1 channel blockade.
    Brain. 2021 Jul 24. pii: 6327685. doi: 10.1093.
    >> Share


    Dement Geriatr Cogn Disord

  11. HEMRUNGROJN S, Tangwongchai S, Charoenboon T, Panasawat M, et al
    Use of the Montreal Cognitive Assessment Thai Version to Discriminate Amnestic Mild Cognitive Impairment from Alzheimer's Disease and Healthy Controls: Machine Learning Results.
    Dement Geriatr Cogn Disord. 2021 Jul 29:1-12. doi: 10.1159/000517822.
    >> Share


    J Alzheimers Dis

  12. WANG F, Xu CS, Chen WH, Duan SW, et al
    Identification of Blood-Based Glycolysis Gene Associated with Alzheimer's Disease by Integrated Bioinformatics Analysis.
    J Alzheimers Dis. 2021 Jul 19. pii: JAD210540. doi: 10.3233/JAD-210540.
    >> Share

  13. CROSS DJ, Huber BR, Silverman MA, Cline MM, et al
    Intranasal Paclitaxel Alters Alzheimer's Disease Phenotypic Features in 3xTg-AD Mice.
    J Alzheimers Dis. 2021 Jul 23. pii: JAD210109. doi: 10.3233/JAD-210109.
    >> Share


    J Biol Chem

  14. SATO K, Watamura N, Fujioka R, Mihira N, et al
    A 3(rd) generation mouse model of Alzheimer's disease shows early and increased cored plaque pathology composed of wild-type human amyloid beta peptide.
    J Biol Chem. 2021 Jul 27:101004. doi: 10.1016/j.jbc.2021.101004.
    >> Share

  15. CHECLER F, Afram E, Pardossi-Piquard R, Lauritzen I, et al
    Is gamma-secretase a beneficial inactivating enzyme of the toxic APP C-terminal fragment C99?
    J Biol Chem. 2021;296:100489.
    >> Share


    Lancet Neurol

  16. FAGAN AM, Henson RL, Li Y, Boerwinkle AH, et al
    Comparison of CSF biomarkers in Down syndrome and autosomal dominant Alzheimer's disease: a cross-sectional study.
    Lancet Neurol. 2021;20:615-626.
    >> Share

  17. FRISONI GB, Hansson O
    Management of Alzheimer's disease takes a leap forward.
    Lancet Neurol. 2021;20:586-587.
    >> Share


    N Engl J Med

  18. DUNN B, Stein P, Temple R, Cavazzoni P, et al
    An Appropriate Use of Accelerated Approval - Aducanumab for Alzheimer's Disease.
    N Engl J Med. 2021 Jul 28. doi: 10.1056/NEJMc2111960.
    >> Share

  19. RABINOVICI GD
    Controversy and Progress in Alzheimer's Disease - FDA Approval of Aducanumab.
    N Engl J Med. 2021 Jul 28. doi: 10.1056/NEJMp2111320.
    >> Share


    Nat Rev Neurol

  20. WOOD H
    Astrocytic IL-3 could help microglia protect against Alzheimer disease.
    Nat Rev Neurol. 2021 Jul 28. pii: 10.1038/s41582-021-00546.
    >> Share


    Neurobiol Aging

  21. RUSSO ML, Molina-Campos E, Ybarra N, Rogalsky AE, et al
    Variability in sub-threshold signaling linked to Alzheimer's disease emerges with age and amyloid plaque deposition in mouse ventral CA1 pyramidal neurons.
    Neurobiol Aging. 2021;106:207-222.
    >> Share


    Proc Natl Acad Sci U S A


  22. Correction for Sun et al., Selective filtering defect at the axon initial segment in Alzheimer's disease mouse models.
    Proc Natl Acad Sci U S A. 2021;118.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016